Via Nova Therapeutics, Inc. — Form D
Via Nova Therapeutics, Inc. of OAKLAND, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-15. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-15
- Form: D
- Accession: 0001882697-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 2
- Date of first sale: 2021-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413505
Issuer
- Name: Via Nova Therapeutics, Inc.
- CIK: 0001882697
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1111 BROADWAY, OAKLAND, CA, 94607
- Phone: 510-227-2102
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Donald Ganem | Director | OAKLAND, CA |
| Joseph Jimenez | Director | Oakland, CA |
| Benjamine Liu | Director | New York, NY |
| Ilan Zipkin | Director | OAKLAND, CA |
| Donald Ganem | Executive Officer | OAKLAND, CA |
More